Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Bedoy AD"'
Autor:
Carter BZ; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Mak PY; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Muftuoglu M; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Tao W; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Ke B; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Pei J; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Bedoy AD; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Ostermann LB; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Nishida Y; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Isgandarova S; Center for Infectious and Inflammatory Disease, Texas A&M University, Institute of Bioscience and Technology, Houston, TX., Sobieski M; Center for Translational Cancer Research, Texas A&M University, Institute of Bioscience and Technology, Houston, TX., Nguyen N; Center for Translational Cancer Research, Texas A&M University, Institute of Bioscience and Technology, Houston, TX., Powell RT; Center for Translational Cancer Research, Texas A&M University, Institute of Bioscience and Technology, Houston, TX., Martinez-Moczygemba M; Center for Infectious and Inflammatory Disease, Texas A&M University, Institute of Bioscience and Technology, Houston, TX., Stephan C; Center for Translational Cancer Research, Texas A&M University, Institute of Bioscience and Technology, Houston, TX., Basyal M; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Boettcher S; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Wallner B; Samus Therapeutics Inc, Topsfield, MA., Morgan RA; Samus Therapeutics Inc, Topsfield, MA., Karras GI; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center, UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX., Moll UM; Department of Pathology, Stony Brook University, Stony Brook, NY., Andreeff M; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood [Blood] 2023 Sep 21; Vol. 142 (12), pp. 1056-1070.